Published in J Virol on August 01, 2001
The Trojan exosome hypothesis. Proc Natl Acad Sci U S A (2003) 3.45
Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol (2003) 2.11
Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol (2002) 1.81
Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol (2002) 1.64
Lipids and membrane microdomains in HIV-1 replication. Virus Res (2009) 1.51
Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur Biophys J (2007) 1.29
Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression. J Virol (2002) 1.16
The Role of Lipids in Retrovirus Replication. Viruses (2010) 1.07
Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J Virol (2005) 0.97
Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions. J Virol (2002) 0.96
Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission. J Virol (2009) 0.93
Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus. J Virol (2002) 0.91
Cholesterol dependence of HTLV-I infection. AIDS Res Hum Retroviruses (2005) 0.90
The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties. PLoS One (2012) 0.85
Function of membrane rafts in viral lifecycles and host cellular response. Biochem Res Int (2011) 0.82
Functional rafts in cell membranes. Nature (1997) 38.89
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol (1998) 8.91
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol (2000) 6.47
Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J (1997) 5.52
Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem (1999) 4.83
LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity (1998) 4.56
Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry (1995) 3.36
Membrane microdomains and caveolae. Curr Opin Cell Biol (1999) 3.34
Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J (1998) 3.22
The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J Immunol (1992) 3.05
Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains. J Biol Chem (1998) 2.78
Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses (2001) 2.60
Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol (2000) 2.40
Both sphingolipids and cholesterol participate in the detergent insolubility of alkaline phosphatase, a glycosylphosphatidylinositol-anchored protein, in mammalian membranes. J Biol Chem (1995) 2.25
Cholesterol is required for infection by Semliki Forest virus. J Cell Biol (1991) 2.24
Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains. J Cell Biol (1996) 2.19
Detergent insolubility of alkaline phosphatase during biosynthetic transport and endocytosis. Role of cholesterol. J Biol Chem (1993) 2.14
Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol (1997) 1.99
Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science (1988) 1.87
Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (review). Mol Membr Biol (1999) 1.82
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J (1994) 1.80
Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J Virol (1999) 1.69
Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV). Int J Cancer (1983) 1.68
The human lymphocyte function-associated (HLFA) antigen and a related macrophage differentiation antigen (HMac-1): functional effects of subunit-specific monoclonal antibodies. J Immunol (1985) 1.67
Homology of human T-cell leukaemia virus envelope gene with class I HLA gene. Nature (1983) 1.58
Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J Virol (1996) 1.53
Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J Biol Chem (1996) 1.49
Production and characterization of monoclonal anti-CD18 anti-idiotype antibodies. Mol Immunol (1989) 1.44
Structure and function of a ganglioside receptor for porcine rotavirus. J Virol (1998) 1.39
Envelope properties of human T-cell leukemia viruses. Curr Top Microbiol Immunol (1985) 1.17
The surface receptor is a major determinant of the cell tropism of influenza C virus. Virology (1987) 1.09
71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. J Virol (1998) 1.01
Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway. J Virol (1989) 0.96
HIV-induced loss of CD44 expression in monocytic cell lines. J Immunol (1993) 0.95
Differential regulation of Src-family protein tyrosine kinases in GPI domains of T lymphocyte plasma membranes. Biochem Biophys Res Commun (1996) 0.91
Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3. Virology (1995) 0.90
Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23. Virology (1993) 0.90
Monoclonal antibodies against porcine LFA-1: species cross-reactivity and functional effects of beta-subunit-specific antibodies. Mol Immunol (1989) 0.90
The role of the ganglioside GD1a as a receptor for Sendai virus. Biochemistry (1995) 0.85
Immunological and structural homology between human T-cell leukemia virus type I envelope glycoprotein and a region of human interleukin-2 implicated in binding the beta receptor. J Virol (1988) 0.83
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol (2000) 6.47
A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol (1983) 3.08
Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses (2001) 2.60
Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity. Int J Cancer (1982) 2.55
The primary structure of the beta-subunit of the cell surface adhesion glycoproteins LFA-1, CR3 and p150,95 and its relationship to the fibronectin receptor. EMBO J (1987) 2.52
Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J Virol (1998) 2.46
Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses (1993) 2.36
LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology (2000) 2.07
Purification and characterization of human lysosomal membrane glycoproteins. Arch Biochem Biophys (1989) 1.90
Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science (1990) 1.78
The human lymphocyte function-associated (HLFA) antigen and a related macrophage differentiation antigen (HMac-1): functional effects of subunit-specific monoclonal antibodies. J Immunol (1985) 1.67
Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1. J Virol (1995) 1.43
Presence in India of HIV type 1 similar to North American strains. AIDS Res Hum Retroviruses (1994) 1.37
High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J Neurochem (2000) 1.34
CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry (1999) 1.34
N-D-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry. Biochem J (1982) 1.32
Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. J Immunol (1990) 1.30
Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. AIDS Res Hum Retroviruses (1998) 1.21
Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions. Eur J Immunol (1985) 1.16
Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes. J Virol (1997) 1.16
Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4. AIDS Res Hum Retroviruses (2000) 1.12
Anti-class II MHC antibody induces multinucleated giant cell formation from peripheral blood monocytes. J Leukoc Biol (1992) 1.12
T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis. J Immunol (1999) 1.10
CD63/Pltgp40: a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. Blood (1991) 1.10
HIV acquires functional adhesion receptors from host cells. AIDS Res Hum Retroviruses (1995) 1.09
Flow cytometric methods for the analysis of human basophil surface antigens and viability. J Immunol Methods (1989) 1.00
The channel-forming toxin aerolysin neutralizes human immunodeficiency virus type 1. Mol Microbiol (1999) 0.95
HIV-induced loss of CD44 expression in monocytic cell lines. J Immunol (1993) 0.95
A high-performance liquid chromatographic procedure for the purification of mouse monoclonal antibodies. Anal Biochem (1985) 0.95
An HLA class I specific monoclonal antibody that fails to bind to all HLA-A antigens. Hum Immunol (1985) 0.93
IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils. J Immunol (1990) 0.91
Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1. AIDS Res Hum Retroviruses (1999) 0.89
CD4-independent, CCR5-dependent simian immunodeficiency virus infection and chemotaxis of human cells. J Virol (2000) 0.86
3-Deaza-adenosine and inhibition of HIV. Lancet (1992) 0.85
Identification of a human Ia antigen that is different from HLA-DR and DC antigens. Immunogenetics (1983) 0.84
Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge. J Infect Dis (1993) 0.83
Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. Surgery (1998) 0.81
Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells. Eur J Immunol (1982) 0.79
Assessment of cell binding to hyaluronic acid in a solid-phase assay. Anal Biochem (1996) 0.77
Simian immunodeficiency virus SIVsmmPBj 1.9 induces multinucleated giant cell formation in human peripheral blood monocytes. AIDS Res Hum Retroviruses (1994) 0.77
A monoclonal antibody against a novel 20-kDa protein induces cell adhesion and cytoskeleton-dependent morphologic changes. J Immunol (1992) 0.76
Factors modifying protective effect of anti-CD18 antibodies on myocardial reperfusion injury in dogs. Am J Physiol (1996) 0.76
Antibody to human MHC class I inhibits SIVsmmPBj1.9-induced proliferation of pigtailed macaque lymphocytes. Exp Clin Immunogenet (1997) 0.75
Involvement of lymphocyte function-associated antigen-1 (LFA-1) but not ICAM-1 in a radioactive leukocyte cell-mediated immunity (LA-CMI) assay. J Clin Lab Immunol (1990) 0.75
Anti-HLA class I antibody inhibits Staphylococcus enterotoxin A (SEA)-induced proliferation of human PBMC. Cell Immunol (1996) 0.75
Plasma membranes from influenza virus-infected cells induce in vitro human secondary virus-specific cytotoxic T lymphocyte responses. Mol Biol Med (1983) 0.75